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Sulphonilamide or para~aud.no benzene sulphonamide
N was first synthesised by G-elmo in
2
1909* In 1935, Domagk showed that when a sulphonilamide
nucleus was contained in an azo dye it prevented the
development of streptococcal septicaemia in mice.
This dye, used originally in pharmacy under the name
Prontosil, later as Prontosil Rubrum or sulphamido-
chrysoidin, was very efficacious, but had the disadvantage
of low solubility, with some toxicity. It was later shown
that it was the sulphonamide nucleus that was responsible
for the activity and that it was less toxic than the azo
dye. Sulphonilamide given by the mouth is absorbed very
rapidly, concentration in the blood reaching^maximum
in four hours. Excretion begins very shortly after
administration.
Sulphonilamide when administered by oral methods was
found to produce certain toxic conditions, such as nausea,
vomiting and cyanosis, despite its success as a
chemotherapeutic agent. It was to eliminate or lessen
these undesirable side effects which prompted the
production of derivatives formed by substitution of the
-NH2 or -S02NHz groupings. Earlier derivatives all had
the substituent in the ~S02NHi group, and these have been
much more freely used in medicine than those derivatives
2.
in which substitution is in the -NH2 group. Some
derivatives, for example, sulphaguanidine, have been found
of use in specific cases; while others are useful in a
variety of infections.
It is now considered that the absolute bacteriological
efficacies of all the sulphonilamides are very similar
and that the large difference in medicinal efficacy between
the various derivatives is due to differences in
solubility, rate of absorption into the blood stream and
rate of excretion in the urine. The necessity from the
pharmaceutical side for a comprehensive list of
solubilities at varying temperatures is therefore obvious.
The solubility of most sulphonilamide derivatives
is much lower than that of the parent substance. Thus,
although the compound may be absorbed very rapidly and
completely from the intestinal tract into the blood stream
it is excreted rapidly by way of the kidneys and a high
concentration is established in the urinary tract. This
tends to lead to crystallisation in the tract and
constitutes a danger to the patient. Since medication is
often in tablet form or as a suspension, the intake of
fluid sufficient to avoid crystallisation in the urine
can be calculated if the solubility is known.
Sulphonilamide, sulphathiazole and sulphamezathine are
also employed as dusting powders incorporating Penicillin,
3.
and absorption by the slcin may lead to poisoning,
especially in the case of burns.
In the case of some derivatives}sodium compounds,
which are readily soluble, can be prepared. However,
the solutions are highly alkaline, due to hydrolysis, and
administration by intravenous injection is painful.
?^hen this type of injection is necessary the solubilities
are important to determine the minimum quantity of
solution to be given.
Since 1939-1940, there have been some measurements
made on the solubility of sulphonilamide and some of its
derivatives in various solvents, but no complete
investigation of comparative solubilities has been made.
3
Kiele and Sayward determined the concentration of
aqueous saturated solutions of sulphonilamide and its two
isomers, ortho- and metanilamide at fifteen temperatures
on 4"
between 23 and 50 C. Sapozhikova and Postovskii
measured the solubility of sulphonilamide, sulphaguanidine,
sulphapyridine, sulphathiazole and sulphethylthiazole and
their acetyl derivatives between 20° and 30° G. The
N' heterocyclic derivatives had the lowest solubility.
Both pairs of workers calculated the heats of solubility.
Using a photoelectric colourimeter to measure the amount
dissolved, Clark, Strakosch and Levitan determined the
solubilities at 25" and 37°C. of sulphonilamide,
4
sulphathiazole, sulphapyridine, sulphadiazine and their
sodium salts.
The influence of pH on the solubility of the
sulphonilamides has been investigated by a number of
3
workers. Kiele and Sayward found that there was a
minimum in the solubility versus pH curve in aqueous
o 6
solutions at 37 C. between pH 4-7. Hug obtained a
similar result at the same temperature using sulphapyridine
and the acetyl derivative. He found that the solubility
7
in urine was slightly greater. Rose, Martin and Bevan,
8
Gilligan and Plummer, and later, Frisk, Haggermsn,
9
Helander and Sjorgen found that in citrate or phosphate
buffers at 37 C., the solubility of sulphamerazine and
sulphamezathine, sulphadiazine, sulphathiazole and their
N-4 acetyl derivatives increased very rapidly above pH 6.
The same phenomenon occurs in urine solution with
n
sulphathiazole and sulphadiazine. Sulphapyridine,
7
however, shows no increase in solubility up to pH 8.
The change in solubility with pH has been discussed from a
•Jo
physico-chemical point of view. Also, the solubility
of some sulphonilamide derivatives has been measured in
is
phosphate buffers and urine, and water, 0.9 per cent.
±4-
sodium chloride solution and blood serum, at different
pHs. The addition of pectin has been found to increase




The solubilities of some sulphonilamides have been
16
determined in aqueous solutions of diethylamine,
17 is
in acetone and in isopropyl alcohol.
The manufacturers of sulphonilamides have also put
out literature which includes figures of solubility.
No details, however, are given in the pamphlets, and very
often expressions such as "very slightly soluble" are used.
The solubilities of very large numbers of organic
compounds are known, but from the physico-chemical point of
view the data have been mainly correlated with regard to
the solubilities of the same solute in different solvents
(e.g. Hildebrand ).
Very little direct work appears to have been done on
the complementary problem of the solubilities of groups of
related compounds in the same solvent. It has, of course,
long been known that similarity appears to favour
solubility - for example, that naphthaline is very soluble
in benzene, but much less so in acetic acid or alcohols.
2o
In connection with this Prins concluded that the
solubility of organic compounds in hydrocarbons does not
depend directly on the polar or active groups, but upon
21
the saturated carbon group. Pastak Investigated the
relative solubilities of substituted benzene derivatives,
biphenyls and and j& naphthalenes from the point of
6.
view of the crystal structure of the solid. He found
that the most soluble isomers possessed the greatest
degree of crystal symmetry.
The dependence of the solubility of pyranase sugars
22
on their structure and the effect of addition of -SO 3 H
or -COOH groups on the solubility of drugs 25 have also
been studied*
Some work has been done of the comparative
solubilities of aliphatic compounds. Borough, Glass,
24-
Greshaa, Malone and Held measured the solubilities of
twenty four isomeric octanols in water, while Hoerr,
Balaton and their co-workers have given data in a series
25
of papers on the solubilities of normal paraffins,
26 27
normal aliphatic alcohols, ketones, saturated fatty
23 29
acids, amides, anilides and N, *1 phenylanilides,
3o
and amines, in numbers of organic solvents. The
solubility decreases in any solvent with increasing chain
length, as might be expected, and the solubility curves
show breaks and a characteristic deviation from a smooth
relationship between solubility and temperature.
The sulphonilamide drugs form an interesting series
of compounds for the study of comparative solubility, since
they all contain the same aromatic nucleus.
- H N >- NH-
with different organic groups at either or both ends* The
7
Importance in pharmaceutical work of a knowledge of their
solubilities has been stressed earlier*
Earlier in this introduction previous work on the
solubilities of some of these substances was summarised*
There is considerable discrepancy between values found by
different workers, due to different methods and conditions
of measurement used. The solubilities in water of
sulphonilamide, a number of its derivatives and their




Procedure* A quantity of each compound was weighed
and placed fa 100 mils of distilled water in a glass
boiling tube, which was fitted with a rubber cork, through
which a calibrated Centigrade thermometer, reading in
degrees, and a stirrer passed* The boiling tube was
placed in an outer glass tube and the whole apparatus was
heated in a water or glycerin bath, the temperature of
which was slowly raised, until the powder in the inner tube
dissolved* The apparatus was then cooled, with
vigorous stirring, until the substance began to crystallise.
The reading of the thermometer was taken to the nearest
;an to form, and was
repeated until several readings for the crystallisation
Several weights of each sulphonilamide were taken.
Materials* The sulphonilamide and all the
derivatives, except N-4 succinyl-sulphonilamide, were
commercial products for direct pharmaceutical use* The
purity is given in the British Pharmaeopoeia as 99 per
cent., and thus they were not further purified. Four of
the derivatives contained water of crystallisation.
The experiment was
temperature consistent to 1 - 2° C. were recorded.
9.
Preparation of N-4 Succinyl-sulphonilamide.
The method of Miller, Rock and Moore 34 was used.
Ten grammes of succinic anhydride and 17»2 grammes of
sulphonilamide with 100 mils of absolute alcohol were
refluxed for 10 minutes, when a crystalline solid was
deposited. The refluxing was continued for five minutes
and the mixture then filtered whilst hot. The filtrate
was cooled and the N-4 succinyl-sulphonilamide




Table I shows the solubilities of sulphonilanide and















^(p-amino benzene 0.035 68
Sulphamido)-pyrimidiriej 0.075 80
Sulphamerazine 0.075 55
^(p-amino benzene - 0.10 60
Sulphonamido) - 4 methyl 0.15 70
Pyrimidine ] 0.175 76
0.20 80
Sulphapyridine 0.062 40















pyrimidine oiv 0.275 70




[3 (p — amino benzene - 0.375 49










































































jp-ethyl, a-sodium 87.5 50













Graphs I to VI are plots of solubility against temperature.
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15.
For any saturated solution of a pure solid in a
liquid solvent, the following relationship between
solubility and temperature applies
where & is the activity of the solute in the saturated
solution at temperature T and pressure P. H0 is the
molar heat content of the pure solid solute and H its
partial molar heat content in the saturated solution.
If the solution is dilute, as is the case for these
aqueous solutions of the sulphonilamides, the activity
can be replaced by the mole fraction of the solute N.
Equation (D then becomes
H - is actually the differential heat of solution
of the solute in the saturated solution under the given
conditions, but for a dilute solution this is practically
the same as the integral heat of solution:- A H.
d T RT 1
16.
32
which is the equation first deduced by Schroeder. Thus
it is possible to determine the heats of solution of the
sulphonilamides from their solubilities at various
temperatures by utilising the integral form of equation (3)
Integrating between temperatures T , and T 2 and
mole fraction solubilities N , and N 2, we obtain, on the
assumption that AH remains constant over the temperature
range,
AM ( ± - ± \T N, n T, )
Integrating the Schroeder equation generally gives
©
^ — + Coi4st*£u4t
RT
Thus, in order to calculate the heat of solubility from
equations on © mole fraction solubilities should
strictly be used.
However, owing to the high molecular weights of the
sulphonilamides compared to that of water even the
saturated solutions of the sodium salts are dilute enough
so that -n. 6,
where S is the solubility in grammes/ 100 mils water.
This can be illustrated for the case of the most
17.
concentrated solution found, that of sulphacetamide sodium
monohydrate.
NH2<3>SO2N - COCH3i H^o has a molecular weight of 254*2,
Its solubility is 100 G./ 100 mils (&*« ) at 35® C.
and 150 (J./ 100 mils (S 2 ) at 80° C.
O
at 35 C. N ,
at 80° C. N 7
• M,
loo / 1 O O
+
18




2.514." 2 / 25 loo
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N
6 £9 * — • 6 & "J.
I s.
She error is seen to be only 3$# which is within the
experimental error.
Thus equation ® can be written
L'l,0$ = " 2-stsR (t)+ ".sUrft
The plot of log S against "y should be a straight
line, the slope of which is » AH
2 3o^
Graphs VII to XI show this plot for the compounds
studied. In all cases reasonable straight lines were
obtained, and AH was calculated from the slope.
18.
For example:- for sulphathalidine, Graph VII,
taking points A and B on line 2 the gradient
— 1*785- (- I- *28if )




A H = lo, ifOA
Equation (§) can he written as ®
where a and h are constants for any compound. a and b
can also he calculated from graphs VII to XI.
9
For example:- for sulphathalidine the gradient
s a a . 2268 and for point A - 1*783 = *2268 (.0030) + b
h = 6.804 - 1.783 = 5.02.
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Compound (mean value over
temperature range )
a b
Sulphacetamide 3970 - 865 2.90
Sulphamezathine 4400 - 960 2.23
Sulphonilamide 5960 -1300 4-46
Sulphathiazole 7650 -1670 4-74




Sulphamerazine 9200 -2000 4.99




Sulphapyridine 14.700 -3200 9.03
Sulphadiasine 15-260 -3330 8.31
Sulphacetamide-



















3740 - 815 4.78







MarfeniX 21.500 -4700 15.82
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By substituting the values of a and b in equation^
the solubility of any sulphonilamide may readily
calculated at any temperature.
Assuming equation (2) to be valid over the
temperature range 20 - 100° C. in each case, values were
calculated for the solubility of the compounds at 200 C.f
i.e. approximately room temperature, and at 35*5° C., i.e.
normal body temperature. These values are obviously
of interest pharmaceutically.
The solubilities are given in Table IV.
22.
TABLE IV.



























Derivative Solubility at 20° C.in Grammes/100 mils.
Solubility at 35.5°G
in Grammes/100 mils






thiazole sodium 100 140
24.
DISCUSSION.
Part I. Comparison of the results of different workers.
Other work on the solubilities of sulphonilamide
derivatives in water is fragmentary. Solubilities given
in the British Pharmacopoeia and the British Pharmaceutical
Codex are often vague, e.g., the solubility of succinyl-
sulphathiazole is said to be "very slight" in water, and
sulphamezathine is said to be "sparingly soluble".
Statements of approximate solubilities are intended to
apply at ordinary room temperatures. The methods
employed by commercial firms to determine the solubilities
published in their pamphlets are not generally given.
Probably a solution is evaporated to dryness and the residue
weighed.
s
Clark, Strakosch and Levitan found that
sulphapyridine had a solubility of 0.0486 grammes per 100
mils at 36° C., and gave other solubilities by other
workers as being in the range from 0.0495 to 0.0530. In
a pamphlet published by a commercial firm, the solubility
is given as 0-0520 grammes in 100 mils at 37° C. In the
present investigation, a solubility of 0.0490 grammes in
100 mils at 35•5° C. resulted from several experiments, in
good agreement with these previous values. Commercial
sources gave the solubility of sulphamerazine and
25
sulphacetamide as 0.0318 and 0.110 grammes per 100 mils
respectively at 37° C. ; in this investigation the
solubilities were found to be 0.0340 and 0.127 grammes
per 100 mils at 35*5° C. Kiele and Sayward 3 give the
solubility of sulphonilamide as 1«37 grammes in 100 mils
at 35*5° C., as compared with 1.82 grammes in 100 mils in
the present work at the same temperature. At 50° C,
however, there is good agreement; 2.68 as compared to
2.75 grammes per 100 mils.
These workers also found the heat of solubility of
sulphonilamide to be 10,860 and 9»050 cals/mole above
and below 37° C. respectively. The transition involves a
monohydrate. Sapozhikova and Postovskii found that the
heats of solubility of sulphonilamide, sulphaguanidine,
sulphapyridine and sulphathiazole lay between 9500 and
10,600 cals/ mole.
Any large differences between the solubilities or
heats of solubility of any derivative as determined by
independent workers is probably due to the different
methods used, in which complication due to the possibility
of hydrate formation is different. Some hydrates, e.g.
of succinyl-sulphathiazole or sulphaguanidine, are the
normal solid state of the substance. Many others are
probably formed in solution and on crystallisation. In
this investigation the same method has been used to
I
26;
determine both the solubility and A H of each derivative,
and the figures obtained may be legitimately compared.
27.
Part II. Connections between the solubility of
the compounds and pharmaceutical practice*
With the exception of N~4 succinyl-sulphonilamide,
all the derivatives have been used in medicine. Prom the
pharmaceutical viewpoint the necessity for a knowledge of
the solubilities has been mentioned in the introduction,
and the dosage is allied to their solubility and the
danger of crystallisation in the body. For instance,
sulphonilamide, with its relatively high solubility,
is excreted rapidly. A high dose, 5 to 10 grammes per
day for 2 to 3 days, has to be given, but there is not a
serious danger of crystallisation in the urine.
Sulphadiazine is excreted less rapidly than sulphathiazole,
the solubility of the former being approximately one-sixty
sixth of that of the latter at body temperature. In
fact, sulphadiazine has such a low solubility that the
urine must be kept alkaline and large quantities of
liquid must be taken by the patient to prevent
crystallisation. In the administration of sulphamerazine,
with ten times the solubility of sulphadiazine at 35*5° C.,
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Sulphonilamide 164*5 - 166.5 5960 1.05
Sulphacetamide 181 - 184 3970 0.89
Suecinyl-sulpha-
thiazole
188-195 (decomposesi) 8850 0.047
Sulphaguanidine 190-192.5 (after
drying at ULOe C.)
8570 0.233
Sulphapyridine 191 - 193 14700 0.013
Sulphamezathine 196 - 199 4400 0.091
Sulphathiazole 200 - 203 7650 0.113
N-4 Succinyl-
sulphonilamide 209 - 211 11460 1.079
Sulphamerazine 235-239 (decomposes) 9200 0.015
Sulphadiazine 252-256 15260 0.00087
Sulphathalidine 272-273 10400 0.0019
31.
Part III. The Influence of structure on solubility.
(a) Sulphonilamide and its ten derivatives (not sodium
salts and Marfenil),
In a series of related compounds it is generally true
to say that the larger the molecule the smaller the
solubility. Theoretical calculations 33 and experimental
3 if
measurements on the system benzene-diphenyl and on a
number of hydrocarbon mixtures emphasise the
extent to which the heat and entropy of solution depend
on the difference in size of the molecules of the solute
and solvent. Therefore, in Table V, for comparison
purposes, the sulphonilamide derivatives are listed with
their structures, molecular weights, heats of solution and
solubilities at 20° C.
Also, the theory of ideal solubility leads to the
expression
where Tm and A Hf are the melting point and heat of
fusion of the solute, T the temperature of the solution
and N the mole fraction solubility. Table VI lists the
melting points and solubilities of the derivatives. Of
course, the relative solubilities of the different compounds
32*
depends on the temperature chosen, in this case 20° C.,
owing to the different heats of solubility. However,
graphs I to VI show that the order of increasing solubility
is little changed over the temperature range within which
aqueous solutions are possible.
There are 3 types of hydrogen atom in sulphonilamide,
made up of 4 nuclear hydrogen atoms, 2 amino hydrogen atoms
and 2 sulphamido hydrogen atoms. It has been found that
replacement of the nuclear hydrogen atoms has no effect on
the activity of the compound.
fable V shows that substitution in either the -NH a
or -SO j HH2 groups results in a diminution in solubility
which may be as much as over a thousandfold, and the
compounds with the smallest substituents, e.g. sulphaeetamide
and sulphaguanidine have higher solubilities than those
containing heterocyclic rings. A second substituted
grouping, e.g. in sulphathalidine as compared with
sulphathiazole, further lowers the solubility.
Equation (D suggests that, in a series of compounds,
if the heats of fusion are not too different, a solid with
a higher melting point should be less soluble than one with
I 9
a lower melting point. Unfortunately there appear* to
be no data in the literature on the heats of fusion of the
sulphonilamides. It can be seen from Table VI that,
although the two compounds with the lowest melting points
33
(sulphonilamide and sulphacetamide) have the highest
solubility and sulphadiazine and sulphathalidine, with the
lowest solubilities have the highest melting points, there
is little corrirlation in between. In fact, succinyl
sulphathiazole and sulphaguanidine, with approximately
the same melting point and even heats of solution, have
very different solubilities. If equation (D did apply,
then the heat of solution should actually equal the heat
of fusion and at the melting point of the substance, log
N should equal zero. This condition is not fulfilled.
Assuming A H is equal to A Hf, at 165*5°C. for
sulphonilamide using equation , log |0 K =-1.484
and for the other substances the value is even less at
their melting points. In any case it seems very unlikely
that ideal conditions are present owing to the highly
polar nature of the solvent water.
Before looking more closely into the variation of
solubility with the structure of the derivatives, it is
necessary to consider the process of solution of the solid.
51
Following Calvat and Sebille two stages may be
distinguished with water as a solvent. Firstly,
absorption of some solvent into the lattice structure, sua
exothermic process, and secondly, the rapid destruction of
this structure, giving the solution. This final process
will, of course, be endothermic, and the total heat change
34.
will be equal to the heat of solution A H. Since A H
is positive, heat is absorbed during solution of any-
derivative investigated, as expected. In other words any
heat liberated AH&Ji in the first process of solution is
more than compensated for by a larger amount of heat
absorbed (Ah^) in the second. The value of A Ha and
A H tL will depend on the crystal structure of the
substance, whether open enough for water molecules to
penetrate inside easily? and the intermolecular forces
between molecules in the crystal and molecules of the
sulphonilamide and water. All these factors will be
influenced by the molecular structure of the derivative.
Thus it is possible to discuss the connection between
both the heat of solution and the solubility of the series
of drugs and their formulae. However, AH and S are to
a certain extent interconnected. For instance, from Tables
V or VI, it appears that to some extent derivatives with
high solubility have low A Hs and vice versa. So
variations in both will be considered together.
All derivatives are weak acids except sulphaguanidine,
which is basic only. However, sulphonilamide,
sulphacetamide, sulphapyridine, sulphadiazine, sulphathiazole
sulphamerazine and sulphamezathine contain both acidic and
basic groups. No one appears to have measured the
dissociation constants of these acids, and so it would be
35
unprofitable to attempt to find any connection between
acidity or basicity and solubility. Sulphaguanidine has
a higher solubility than the acid derivatives generally,
but less than sulphacetamide of the same molecular weight.
One point may be noted, howevert N-4 suceinyl- sulphon-
ilamide and succinyl sulphathiazole, which can be considered
as derivatives of succinic acid have comparable
solubilities, while sulphathalidine, a derivative of
JsLtLcJjc. acid is twenty to forty times less soluble.
The simplest molecules, sulphonllamide and
sulphacetamide, have the two lowest heats of solubility.
This might imply that less energy is required to break up
the crystal lattice in these cases, than with the larger
molecules, which might be partly coiled round each other in
the solid state. Sulphathiazole, succinyl sulphathiazole
and sulphathalidine show a progressive increase of A H,
with increase in size of the side group attached in the
para position to the -SO^NH-Th group. However,
sulphaguanidine and succinyl sulphathiazole, though
greatly different in size, have very much the same heats
of solubility, 8570 as compared with 8850 cals.
Sulphadiazine is formed from sulphapyridine by the
replacement of a -CH group by a nitrogen atom in the
pyridine ring. This has little effect on the heat of
solubility, which is relatively very high. Evidently the
36.
crystal forces are strongj and probably the molecules are
close-packed, owing to the symmetry of the two six-membered
rings, and water molecules cannot penetrate the lattice
easily. The substitution of a diazine for a pyridine
ring, apparently does not affect this, but it does affect
their solubilities. The solubilities of both are
relatively low, but sulphadlazine is surprisingly about
fifteen times less soluble than sulphapyridine.
However, the change to a five-membered heterocyclic
ring in sulphathiazole, as well as the substitution of a
sulphur for a nitrogen atom, approximately halves the heat
of solubility, while increasing the value of the
solubility considerably. It is impossible to say
whether one or both of the structural changes is the cause
of the change in AH and S.
The most startling result, perhaps, is the large
change in solubility and heat of solution by the
introduction of one, and then two, methyl groups into the
heterocyclic ring of sulphadiazine. AH drops from
15,260 to 4,400 cals/mole, while the solubility increases
one hundred fold. The replacement of a hydrogen atom in
a -CH group in a heterocyclic ring by -CH3 does not
generally change the physical or even the chemical
properties of the compound to any great extent. It seems
unlikely that the intermolecular forces in sulphadlazine,
37.
sulphamerazine and sulphamezathine axe greatly different.
Thus the effect on the heat of solution is probably due to
steric hindrance. The introduction of one, and then two
-CH 5 groups progressively disorders the close-packed
structure. Water molecules can penetrate more readily as
a preliminary to the easier breakdown and dissolution
of the crystals.
(b) The Sodium salts, B.O.S. and Marfenil.
The sodium salts are formed by the replacement of the
amido hydrogen atom by sodium, e.g. sulphacetamide sodium
has the formula
Ha ^ ~ < >- N - CacH,
I 3
Net
except succinyl sulphathiazole sodium; formula
^HfCOoNa
I





E.O.S. has the formula Na Sovc H;HM-<—yso, kIh?
while Marfenil is the hydrochlorideHh2-HC^
The latter is in a class by itself. Owing to its being a
strongly electrovalent compound (the formula should be
written - cH2-<ZI>-so2 NVI^+ cl," )> the crystal will
38.
be ionic and the lattice energy very high. This accounts
for the abnormally high heat of solution.
Tables III and IV show that the solubilities of the
sodium salts are very much greater than the corresponding
weak acids, but the variation in solubility is much less
(only about four fold). This is not unexpected as
substitution is in the basic structure of the acid radical.
The heats of solubility are all less than those of the
acids except in the case of sulphamezathine, and are also
relatively low.
The sodium salts are to some extent ionic compounds
and thus it would seem likely that the lattice forces in
the solid would be stronger than in the corresponding
parent compounds. The reduced heats of solution are,
therefore, probably due to easy absorption of water
molecixles in the first stage of dissolution.
From the survey of structure in relation to
solubility it is obvious that there can be no general
correlation between any one property and AH or S.




The solubilities in water of Phthalyl-aulphathiaaole
(sulphathalldine), 2 (p-aniinobenzene-sulphamide ) pyrimidine
(oulphadiazine)t 2(p-aminobenzene-sulphamido)-4 methyl
pyrimidine (aulphamerazine), 2(p-aminobenzene-sulphonilamido)
pyridine (sulphapyri&ine), 2(p-aminobenaene sulphonamido)
4«6 dimethyl pyrimidine (sulphasezathine), 2(p-aminobenzene-
sulphonamido) thiaaole (sulphathiazole)» 2(p-succinyl-
aminobenaene-sulphonamide) thiazole (succinyl-eulphathiaaole
monohydrate), H-4 succinyl sulphonilamide, p-aminobenzene-
sulphonyl-guanidine (sulphaguanidine monohydrate),
p-aminobenaene- sulphonacetamide (sulphacetamide),
p-aminobenzene-sulphonamide (sulphonilamide), seven sodium
salts, and 4-aaino-aetiiyl-benaene-sulphonamide hydroclilorude
(Marfenil) and p-ethyl, a-aodium sulphonate-aminobenaene
sulphonamide (B.O.S.) have been determined by measuring the
temperature of initial crystallisation for solutions of
different concentrations.
It la found that the plote of los, against k where S
is the solubility in grammes per 100 mils and T the
absolute temperature are straight lines and heats of
solubility of the compounds have been calculated. The
constants a and b in the equation
log 40 S « a (Jf) + b, and thus the solubilities at 20° C.
and 35*5° C. have also been calculated.
40
The connection between the pharmaceutical action of
the drugs arid their solubility is discussed.
There is little correlation between the melting points
of the derivatives and their solubilities.
«>
Substitution in either the - KH aor -SO,-, NH ^ groups
results in a diminution in solubility which may be as much
as a thousandfold, and generally the larger the molecule
the smaller the solubility. To some extent derivatives
with a high solubility have a low heat of solution and
vice versa.
The variation in the heat of solubility is discussed
from the point of view of the packing of the molecules in
the crystal.
The sodium salts have a higher solubility and a lower
heat of solubility than the parent compounds, though the
variation in solubility is less (about fourfold).
There appears to be no general correlation between any
one property and the heat of solution or solubility, but a
number of factors must be taken into account.
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